Friday, 1 March 2013

First gene therapy study in human salivary gland shows promise

This finding comes from the first-ever Phase I clinical study of gene therapy in a human salivary gland. Its results show that the transferred gene, Aquaporin-1, has great potential to help head and neck cancer survivors who battle with chronic dry mouth.
crawled from : Sciencedaily

No comments:

Post a Comment